Research and Practical Innovation

Current status: NDCP is inactive with no plans for revival. This site describes an example organisation, not current operations. Details.

Research should help autistic people live better, not merely explain why their lives are difficult.

The Researcher Alliance should build dependable partnerships, not assume that cooperation is absent. A Singapore study published in 2026 involving 20 autistic adults brought autistic and non-autistic researchers together to examine workplace needs and possible AI support. It provides a local precedent for collaboration, not evidence that an AI tool improves employment outcomes. Small studies can answer useful questions. The proposed partnership should make recruitment more reliable, return findings to participants and move from identifying needs to testing practical improvements.

The priority is improved functioning and quality of life at a cost people can sustain. Functioning includes communication, daily living, attention, adaptability, emotional regulation and the capacity to pursue chosen activities. Better sleep, less discomfort or a more workable environment can matter as much. These are research goals, not a claim that any one intervention improves all of them.

Researchers as working partners

Any suitable institution or independent team can propose work: universities, healthcare providers, educators, engineers, social scientists and community researchers. A project is judged on relevance, scientific quality, competence, safety, resources and usefulness, not on whether its investigators belong to a preferred network.

Autistic contributors decide which questions matter, whether the procedures are manageable and what counts as a worthwhile change. Caregivers contribute observations where the participant agrees or the legal framework provides for it. Researchers are responsible for sound methods and an honest account of uncertainty; clinicians keep clinical responsibility. NDCP contributes community knowledge, accessible communication, coordination, citizen scientists and trained help with agreed study tasks; the institution supplies the scientific and regulatory infrastructure. Payment, data custody, authorship, publication and any commercial interest are written down. Participation in NDCP is never a condition of ordinary clinical care.

Over time the proposed partnership could maintain an opt-in contact pool, open to willing members and non-members, and a separately governed reusable research dataset. Each study would still establish eligibility and separate consent. Broad invitations through ordinary professional, alumni and interest networks would complement community recruitment; nobody would nominate suspected autistic colleagues. Private contributions would not require a public autism identity. Groups neglected in the literature, such as autistic women and older undiagnosed adults, would be deliberately included where relevant to the research question.

Direct testing of low-cost supplements

Low-cost supplements are squarely within the remit. NDCP develops and runs controlled studies with qualified researchers and clinical partners to test whether a specified preparation improves a defined difficulty in a defined group of autistic participants. The question is what works, for whom, at what cost and with what adverse effects. Some participants may benefit during a study; others may see nothing or experience side effects. Consent, clinical oversight and safety monitoring are part of the research, not obstacles to it.

Published trials show why direct testing matters. Sulforaphane treatment of autism spectrum disorder reported improvements on several behavioural and social measures in a randomised study of 44 males aged 13 to 27 with moderate-to-severe autism. Sulforaphane Treatment in Children with Autism: A Prospective Randomized Double-Blind Study found no significant improvement on its behavioural outcomes in children aged 3 to 7. Neither establishes effectiveness for adults with low support needs or for retail products of a different composition. They illustrate a research question, not a recommendation. A supplement being cheap, natural or sold over the counter says nothing about its purity, dose, interactions or suitability, so product identity, consistency and supply are part of the study.

What a joint clinical study looks like

A community question goes to a qualified study team, which reviews existing evidence, alternative explanations and risks before proposing a protocol. The research institution and sponsor take responsibility for ethics and regulatory review; NDCP’s committee does not approve its own clinical experiment. The protocol specifies eligibility, the preparation and clinician-determined administration, a comparison group, outcomes, follow-up and adverse-event procedures, with randomisation and blinding where appropriate. Outcomes and analysis are specified and the trial is registered before recruitment. An exploratory study is reported as exploratory, however affordable its sample.

The investigator reviews relevant health conditions, medicines and other supplements. Necessary care is not withheld to flatter the experiment. Monitoring, access to clinical help, stopping rules, research-injury arrangements and follow-up are funded before anyone receives the intervention. Members are never asked to organise group self-experimentation, combine products informally or change prescribed treatment on a volunteer’s advice.

In Singapore, the HSA overview of clinical trials brings health supplements investigated for disease treatment or prevention within the regulated clinical-trial framework, and the institution determines what applies under the human biomedical research framework. Calling a project community research or product feedback does not settle those obligations.

Research beyond supplements

  • Health and everyday functioning: sleep, nutrition, physical activity, sensory environments, audio dampening, and the practical effects of co-occurring conditions. A diagnosed health problem goes to appropriate care; it does not wait for community research.
  • Learning and communication: comparisons of rehearsal, explicit instruction, creative activity, peer learning and assistive tools, judged by whether the person can use the skill outside the session, the support still needed and the effort or distress involved.
  • Work and independent living: job design, accommodations, task-synchronisation tools, family enterprises, shared living and the real cost of support. The autistic person’s autonomy and experience count, not only an employer’s satisfaction or a caregiver’s reduced workload.
  • Community support: peer groups, befriending, safety practices and support navigation: who benefits, who drops out, whether dependence on organisers grows and how much facilitator time is needed.
  • Differences within autism: support profiles, co-occurring conditions and variation in response, rather than one average that describes nobody. The masterplan’s dynamic diagnosis proposal is a candidate for joint work with international researchers. The multiple-autisms working hypothesis offers one unproven experiential framework to investigate alongside existing profiles. Diagnostic proposals remain scientific work; NDCP does not issue its own diagnostic system.
  • Autistic parenting and caring: test household routines, communication methods and backup arrangements with autistic adults responsible for children or other dependants. Assess the adult’s goals, the care recipient’s wellbeing, recovery time and the distribution of work across the household.
  • Control over resources and routes into ownership: examine whether participant-directed budgets remove a specific barrier, and whether paid business-succession apprenticeships create viable options. Count administration, unpaid work, commercial risk and unsuccessful attempts, not only completed awards or ownership transfers.
  • Institutional competence: compare a redesigned process, individual coaching and a combination of both where they address the same difficulty. Assess successful completion, errors, time, fatigue and prompting by other people, including whether any apparent saving merely transfers work elsewhere.

Participation beyond current members. A bounded study could include quiet members, former contributors and people who considered joining but declined. Separate motivation to enter, reasons for remaining, handling of concerns, completed terms, later withdrawal and contribution elsewhere. Test whether confidential, limited tasks are more useful than membership or publicity, without requiring return or reconciliation. The AFAM’s participation study keeps exploratory accounts separate from population estimates.

Experience and interaction-sensitive evaluation. Compare what a participant can do separately, under combined demands, in unfamiliar situations and at sustainable cost. Record inner accounts, new capabilities, useful workarounds, continuing assistance, recovery and adverse effects. Test competing explanations before treating an apparent response as confirmation of a mechanism. The experience and interaction study supplies the design questions. These are separately resourced proposals, not current studies or additions to the illustrative core budget.

A proposed adult-life pilot menu

These are specifications for potential adopters with suitable partners and resources, not an operating programme or a commitment to run every study at once. They turn the broader portfolio into questions that can produce a useful decision. The linked AFAM sections explain the rationale and underlying evidence.

  1. Diagnostic precision and continuity. Using consented records or appropriate de-identified cases, qualified researchers could compare recommendations based on an existing functional profile with those informed by a proposed subgroup. Record assessor agreement, which decisions actually change, classification uncertainty and possible continuity problems. No participant’s care or eligibility would be altered simply to test an unvalidated category. Strategic basis.
  2. Starting and resuming. On an adult-chosen, low-risk task, compare the current arrangement with a clearer first action, fewer interruptions, a resumption cue or brief agreed human assistance. Measure completion, errors, delay, recovery and helper time. Keep methods that improve the whole task rather than merely generate more reminders. Strategic basis.
  3. Flexible speech and AAC. Offer a participant-chosen communication option alongside the person’s existing accessible arrangement, without imposing speech-only conditions. Test whether a concern, decision or work message is conveyed accurately with manageable effort. Record misunderstandings, delay, independent authorship and the usefulness of a backup. Strategic basis.
  4. Completed healthcare. With clinical partners, compare usual provision with preparation materials and targeted help at an identified failure point. Measure appropriate assessment, understood next steps, completed follow-up or informed refusal, unresolved needs and staff/helper time. Necessary care continues; fewer appointments are not automatically a better outcome. Strategic basis.
  5. Menstrual and menopausal changes. Begin with feasibility: participant-controlled optional tracking, consultation preparation and suitable temporary adjustments. Examine whether the process identifies relevant changes, supports appropriate assessment and makes daily demands more manageable. Do not infer hormonal causation or prescribe an autism-specific treatment from an exploratory pilot. Strategic basis.
  6. A life the adult wants to sustain. Add a small number of adult-defined outcomes to a selected pilot before it starts: a desired activity or relationship, an unnecessary dependence to reduce and a cost not to conceal. Compare those outcomes with skill, income or service-use changes. Treat these as individual goals, not a newly validated universal wellbeing scale. Strategic basis.
  7. Reciprocal communication. Where the sample and setting permit, compare autistic-participant coaching, partner coaching and paired practice on the same kind of task. Measure accurate understanding, completed work, disagreement repair, rapport and each person’s effort separately. Do not infer benefit simply from matching neurotypes or providing awareness training. Strategic basis.
  8. Bereavement and anticipatory grief. Co-design an optional package of practical continuity, an agreed contact and appropriate referral. First test acceptability, burden, unmet needs and participant-chosen usefulness. Do not require emotional disclosure, withhold necessary care or treat rapid disappearance of grief as the success measure. Strategic basis.
  9. The adult’s own retirement. Test a planning worksheet and, where affordable, a reversible trial routine. Include irregular earnings, administrative responsibilities, desired contact and the functions of work that need replacing. Measure clarity of the plan, manageable demands and chosen later-life outcomes rather than continued employment alone. Financial and legal decisions require appropriate expertise. Strategic basis.
  10. Accessible substance-use support. With qualified providers, examine whether clearer information, written first contact and suitable participation formats help adults reach appropriate care. Record access, understanding, reasons for disengagement and clinical outcomes only where the treatment team can assess them properly. Peer volunteers do not deliver withdrawal or addiction treatment. Strategic basis.
  11. Fair accounts in high-stakes settings. Test a professionally reviewed information-gathering protocol using practice scenarios with known facts. Compare accuracy, omissions, leading prompts, participant burden and clarity of corrections. Transfer to real institutional procedures requires separate approval and evaluation; the exercise must not coach a preferred account in a live dispute. Strategic basis.

Additional learning and investment pilots

Adaptability and transfer. Compare purpose-focused, variable practice with a suitable active alternative on unfamiliar tasks. Examine justified decisions, changed methods, overlooked perspectives, ordinary-life application, support required and delayed costs. Test the bridge and partner-diversity questions separately where possible. The research design distinguishes feasibility from effectiveness and temporal sequence from proof of a prerequisite.

Strategic development and community bonds. Follow a separately funded award through assessment, preparation, qualification or project completion, placement and contribution. Examine recipient and sponsor performance, including unprovided support. Distinguish service hours from quality, qualifications from readiness and recognition from additional value created by the funding. The investment evaluation would count full costs, alternatives, withdrawals and unsuccessful attempts.

A bounded study before a continuing service

Each selected pilot would name its responsible partner, adult-chosen problem, recruitment criteria, comparison, primary outcome, foreseeable burdens, review point and stopping rule before starting. Use proportionate sample descriptions and accessible consent. A feasibility study should be reported as feasibility; an uncontrolled improvement is not proof of treatment effectiveness.

Prefer a simple reusable tool or existing service adjustment before building a new platform. Record setup and running costs, participant effort, family or volunteer time, adverse effects and unsuccessful attempts. Retain necessary support during comparisons. Clinical studies and high-stakes institutional applications require their own qualified oversight and relevant approvals.

Replication or a stronger comparison would precede claims of general effectiveness. Publish useful negative findings and identify who did not benefit. Sensitive data would not be pooled merely because a shared dataset exists. Any expansion would need an explicit funding and handover plan; these proposals do not add specialist provision to NDCP’s illustrative core budget.

Waldorf and other refreshing approaches

NDCP does not adopt Waldorf as a complete system. The AWSNA Principles for Waldorf Schools describe both spiritual foundations and practical features such as rhythm, artistic activity and learning from experience. Our interest is in components that stand on their own: predictable rhythm, continuity of relationships, practical crafts, movement, nature-based activity and meaningful whole tasks. Their spiritual explanations stay outside the programme, and similar components from other traditions are equally welcome.

A component may enhance, complement or replace an existing method when evidence supports that change. Replacement is a legitimate result. Equally, an approach earns no protection from criticism by being alternative, and a structured mainstream method is not automatically dehumanising. For children, the collaboration evaluates learning, communication, wellbeing, the child’s preferences and family burden. Home education is one setting among several; the MOE compulsory-education exemption requirements apply, and NDCP membership does not supply an exemption.

Creative methods with measurable purposes

Creative-learning research would examine what the participant actually practises, not treat every drama programme as the same intervention. The Applied Drama Lab’s evidence review distinguishes the adult theatre trial, its limited social-adaptation finding and qualitative improvisation research. The original adult trial record remains available.

The proposed focus is purpose-level judgement through genuinely contingent interaction: understanding a rule, changing the method when necessary and noticing what the original framework leaves out. Researchers would record independent decisions, partner contributions, facilitator answer-supplying and progression in complexity.

Useful sensory and communication support would remain available. A script could provide access, a process prompt or the starting situation without prescribing every consequential response. Participants choosing developmental improvisation would know which decisions remain open and how to pause or obtain help. Public performance, recording, touch and personal disclosure would require separate agreement.

A bridging route could reduce simultaneous demands while retaining real uncertainty, then introduce more varied partners and responsibilities. It would have review points, a route into fuller participation and alternatives where costs exceed benefit.

Assessment would separate enjoyment, confidence and performance from transfer into new tasks and ordinary life. Follow-up would include recovery, fatigue, unwanted imitation pressure, continuing assistance and unsuccessful attempts. AI-generated dialogue could support preparation but would not demonstrate the learner’s judgement.

The study would test a specified method and population, not assume that a successful personal experience establishes an effective course for everyone. The aim is practical learning with a clear account of who benefits, what makes it work and when to change the approach.

Each study has its own accessible information and consent process naming the investigator, sponsor, purpose, procedures, risks, possible benefits, payment, data use, withdrawal arrangements and an independent contact. Refusal or withdrawal costs nothing in membership rights, social opportunities or unrelated support. Consent is revisited when material information changes. Diagnosis alone does not establish incapacity, and fluent speech alone does not establish understanding; another person’s lawful authorisation is not permission to ignore the participant’s wishes or distress. Child research has its own age-appropriate arrangements and review.

No partner receives the membership list or private conversations. Invitations go through a separate opt-in channel; identifiable information moves only through an authorised process. The HSA information for clinical-trial participants is the external reference on benefits, risks and rights.

Useful results, including disappointment

NDCP and its partners report methods, population, findings, adverse effects, limitations and conflicts in plain language. Negative and inconclusive findings are published; they prevent wasted money, unnecessary burden and misplaced hope. Identifiable quotations or images need separate permission; research consent is not media consent. A favourable trial does not justify a retail treatment claim, and the HSA health-supplement claims rules still apply. Where a method is supported, the partnership develops affordable materials, training or delivery arrangements so the result reaches people beyond the study.

Low-cost intervention does not mean cost-free research. Clinical supervision, product checks, participant expenses, data protection and follow-up sit in a separate project budget. NDCP contributes what a grassroots organisation does well without hiding scientific costs in unpaid community labour.

Reviewed 6 September 2026. Links to other websites open in a new tab.